tiprankstipranks
Trending News
More News >

Encompass Health price target raised to $135 from $116 at Truist

Truist raised the firm’s price target on Encompass Health (EHC) to $135 from $116 and keeps a Buy rating on the shares. The firm remains bullish on the name following Q1 results marked by brisk volumes, better revenue/discharge, strong cost controls and raised FY25 guidance, the analyst tells investors in a research note. Demand trends for Encompass remain robust, occupancy was superb, and payor mix favorable, the firm adds.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1